Purchase Order 1264PP18P0015
- Not listed
- Roche Diagnostics Corporation was awarded a purchase order contract valued at $13,378.38 for LightCycler 480 Probes Master and LightCycler 480 Multiwell Plate supplies. The contract was awarded on September 7, 2018, with an ultimate completion date of September 27, 2018. This firm fixed-price contract was funded by a civilian federal agency under the Midwest Area and performed in Castleton, Indiana. No set-aside designation was used in this award, indicating open competition in the federal...
- Roche Diagnostics Corporation was awarded a $5.5K firm fixed price purchase order by a civilian federal agency within the Midwest Area on June 3, 2016, for a LightCycler 480-96 service agreement with quarterly payments. The contract, which did not utilize a set-aside designation, was completed by July 21, 2017, and performed in Castleton, Indiana. As a leading global manufacturer of in vitro diagnostic equipment and reagents, Roche Diagnostics provides the federal government with advanced...
- This federal contract award was made by a civilian government agency to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The award is for the purchase of a Light Cycler 96 Instrument, with a ceiling value of $18,300.00. The contract is a firm fixed price purchase order without any set-aside designation, indicating open competition. Roche Diagnostics is a global leader...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $5.5K on June 9, 2015, for LightCycler 48-96 coverage (Serial #26230) through a civilian federal agency's Midwest Area office. The contract period runs from July 22, 2015, through July 22, 2016, with performance to be completed in Castleton, Indiana. This award was made without set-aside designations, demonstrating open competition in the federal marketplace. The LightCycler system represents Roche's...
- Roche Diagnostics Corporation was awarded a $18,000 firm fixed-price purchase order by the Southeast Area civilian federal agency on June 17, 2015, for a Light Cycler PCR (polymerase chain reaction) system. The contract, with an ultimate completion date of September 15, 2015, represents a direct acquisition with no set-aside designation. Performance of the work is scheduled to occur in Castleton, Indiana. This purchase order falls within Roche Diagnostics' broader portfolio of federal diagnostic...
- This is a $39,400 firm fixed-price purchase order awarded by the Plains Area of the U.S. Department of the civilian federal agency to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The award is for LIGHTCYCLER 480 and does not have a set-aside designation. Roche Diagnostics holds multiple significant indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) across federal agencies, including a...
- This federal contract award is for molecular testing equipment, with a ceiling value of $247,811.23. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, on July 11, 2025. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a set-aside designation,...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the supply of ROCHE COBAS products. The contract, valued at $150,371.25, is a firm fixed-price purchase order awarded by the Department of the Army Medical Command. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory instruments, and associated products and...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for LIGHTCYCLER products. The $47,000.00 firm fixed price delivery order was awarded by the Pacific West Area, a civilian agency within the U.S. government, under the Multiple Award Schedule (MAS) contract vehicle. The award does not utilize a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $947,520.62, was awarded by the Medical Command within the U.S. Department of Defense on October 1, 2020 for a period ending on September 30, 2021. The contract is a Delivery Order under a Firm Fixed Price pricing type and does not have a set-aside designation....
Roche Diagnostics Corporation received a firm fixed-price purchase order award from a civilian federal agency in the Midwest Area for LightCycler diagnostic equipment, valued at $18,300. The award, issued on June 25, 2018, with a completion date of August 31, 2018, was made without set-aside designation. Performance of the contract is located in Columbia, Missouri. As a foreign-owned manufacturer specializing in in vitro diagnostics and laboratory instruments, Roche Diagnostics supplies critical diagnostic technologies to support federal healthcare delivery across military, veterans, and civilian systems. Roche Diagnostics Corporation is an established federal contractor with extensive experience providing diagnostic solutions to agencies including the Department of Veterans Affairs and Defense Health Agency. The company holds multiple Indefinite Delivery Contracts and Blanket Purchase Agreements through General Services Administration Schedule contracts, including the Critical Analyzers, Laboratory schedule and the In Vitro Diagnostics, Reagents, Test schedule. These contract vehicles enable federal agencies to procure Roche's medical diagnostic technologies through pre-negotiated pricing, and the company's federal contract portfolio demonstrates consistent open competition and ranges from several thousand to several million dollars in value, covering molecular diagnostics, clinical chemistry analysis, immunochemistry testing, and specialized reagent systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.3k | 6/26/18 |